Edwin Charlebois, MPH, PhD
Professor of Medicine
University of California, San Francisco
Co-Director of Methods Core, Center for AIDS Prevention Studies
Co-Director of Prevention, AIDS Policy Research Center / AIDS Research Institute
Dr. Edwin D. Charlebois, III MPH, PhD, is a Professor of Medicine in the Department of Medicine at the University of California, San Francisco (UCSF), Co-Director of the Methods/Biostatistics Core within the UCSF Center for AIDS Prevention Studies (CAPS), and the Co-Director for Prevention for the AIDS Policy Research Center. He been involved in HIV research since 1991, including work on the early cohorts of HIV infected men in San Francisco, the Tri-Continental HIV Seroconverters Study, and studies of HIV epidemiology, anti-retroviral medication adherence, and Methicillin Resistant Staphylococcus aureus (MRSA) infections among the poor and marginally housed. Dr. Charlebois is a PI and co-investigator on multiple NIH studies of the epidemiology of HIV co-infection and treatment for adults with HIV and Malaria and HIV and Tuberculosis in adults and children. In East Africa he is the protocol vice chair of the SEARCH trial, a 320,000 person cluster-randomized trial of community-wide HIV testing and ART regardless of CD4 cell count upon HIV diagnosis (a Test and Treat strategy). Dr. Charlebois is also principal investigator for two NIH funded data and statistical centers in Uganda providing capacity building for research data collection and statistical evaluation and clinical-trial support.
Mobile Community Health Campaigns. There is a high burden of undiagnosed HIV in sub-Saharan Africa, limiting treatment and prevention efforts. Large-scale, mobile community-based HIV testing campaigns can address this challenge and provide an untapped opportunity to identify non-communicable diseases (NCDs). Dr. Charlebois will discuss his experience over the last 10 years in developing and evaluating mobile community health campaigns as a community-level approach to diagnosing and linking to care individuals with HIV and other infectious and non-communicable diseases. He will synthesize important lessons learned from NIMH Project Accept (HPTN-043), the Kakyerere CHC Development Studies, and the SEARCH Trial.